Tuberculosis (TB) is the most deadly infectious disease in the world with
treatment spanning for up to 6 months; however, in case of MDR-TB, it can even
go up to 2 years. Research shows that the cost of developing a new drug is
quite huge. Now, one research published in Scientific Reports shows that first
generation cephalosporins could be a potential treatment for TB. Read more
Microbiology, pharmaceuticals, healthcare and contamination control news and discussion site. Edited by Dr. Tim Sandle (established 2010)
Subscribe to:
Post Comments (Atom)
No comments:
Post a comment
Pharmaceutical Microbiology Resources